Effect of AZD1208 on gene expression in recurrent resistant Myc-CaP tumors grown in castrated mice.

ABSTRACT: AZD1208 is a novel PIM kinase inhibitor that we have shown inhibits tumorigenesis in tissue recombination models, Myc-CaP allograft models, and human prostate cancer xenografts. We sought to determine the intracellular pathways that are responsible for the anti-tumor effect. To this end we used the tissue recombination protocol to implant MYCCaP cells into castrated mice. MYCCaP cells are an androgen-dependent mouse cell line that overexpresses the oncogene MYC. The mice used for implantation were castrated, so any tumors that result from the grafting procedure are androgen-independent. The grafted mice were divided into a control population receiving vehicle, and a test population receiving AZD1208. The tumors were harvested and in vitro cell lines were made. The new cell lines have been

ORGANISM(S): Mus musculus

SUBMITTER: Philip Anderson 

PROVIDER: E-GEOD-59106 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress